Calloway Nathaniel has filed 9 insider transactions across 2 companies since January 2024.
Most recent transaction: a grant/award of 25000 shares of Anebulo Pharmaceuticals, Inc. ($ANEB) on April 04, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 4, 2025 | Anebulo Pharmaceuticals, Inc. | $ANEB | Calloway Nathaniel | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| April 4, 2025 | Anebulo Pharmaceuticals, Inc. | $ANEB | Calloway Nathaniel | Director | A | Stock Option (right to buy) | 3309 | $0.00 | 3,309.0000 | 0 | 9999.99% | 0.00% |
| July 8, 2024 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Calloway Nathaniel | Director | A | Common Stock | 30000 | $0.00 | 58,069.0000 | 0 | 106.88% | 0.00% |
| June 13, 2024 | Anebulo Pharmaceuticals, Inc. | $ANEB | Calloway Nathaniel | Director | A | Stock Option (right to buy) | 1655 | $0.00 | 1,655.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Anebulo Pharmaceuticals, Inc. | $ANEB | Calloway Nathaniel | Director | A | Stock Option (right to buy) | 41667 | $0.00 | 41,667.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Calloway Nathaniel | Director | M | Common Stock | 3981 | $0.00 | 28,069.0000 | 0 | 16.53% | 0.00% |
| Feb. 1, 2024 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Calloway Nathaniel | Director | M | Restricted Stock Unit | 3981 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 9, 2024 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Calloway Nathaniel | Director | M | Common Stock | 5906 | $0.00 | 24,088.0000 | 0 | 32.48% | 0.00% |
| Jan. 9, 2024 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Calloway Nathaniel | Director | M | Restricted Stock Unit | 5906 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |